Diana Bell Selected Research

Sinonasal undifferentiated carcinoma

12/2020	High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
10/2019	Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
1/2019	Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
1/2016	Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.
3/2013	Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Bell Research Topics

Disease

58	Neoplasms (Cancer) 04/2022 - 07/2007
20	Carcinoma (Carcinomatosis) 01/2022 - 01/2010
14	Squamous Cell Carcinoma of Head and Neck 04/2022 - 06/2012
10	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2013
7	Adenoid Cystic Carcinoma (Cylindroma) 08/2020 - 12/2010
6	Adenocarcinoma 01/2022 - 09/2009
5	Sinonasal undifferentiated carcinoma 12/2020 - 03/2013
4	Mucoepidermoid Carcinoma 01/2016 - 04/2008
3	Disease Progression 01/2021 - 01/2010
3	Lymphatic Metastasis 01/2019 - 03/2013
3	Carcinogenesis 01/2016 - 04/2013
2	Sarcoma (Soft Tissue Sarcoma) 04/2022 - 03/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 11/2016
2	Genetic Translocation (Chromosomal Translocation) 08/2020 - 04/2013
2	Autoimmune Diseases (Autoimmune Disease) 02/2020 - 01/2020
2	Pleomorphic Adenoma 12/2019 - 09/2015
2	Chordoma 03/2018 - 10/2016
2	Residual Neoplasm 03/2013 - 04/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011 - 07/2007
1	Exanthema (Rash) 04/2022
1	Lymphadenopathy 04/2022
1	Spontaneous Remission 01/2022
1	Neuroendocrine Carcinoma 12/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Papillary Thyroid Cancer 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Acinar Cell Carcinoma 08/2020
1	Amyloidosis 02/2020
1	Infections 02/2020
1	Lymphoma (Lymphomas) 02/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Oropharyngeal Neoplasms 01/2020
1	Acrospiroma 08/2019
1	Hemangiopericytoma 03/2019
1	Papilloma (Papillomatosis) 01/2019
1	Bone Cysts (Bone Cyst) 12/2018
1	Aneurysmal Bone Cysts 12/2018

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
9	Biological ProductsIBA 04/2022 - 03/2009
8	ParaffinIBA 10/2019 - 01/2010
7	Proteins (Proteins, Gene)FDA Link 08/2019 - 12/2010
5	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
5	Formaldehyde (Formol)FDA Link 10/2019 - 04/2015
5	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016 - 07/2007
4	Messenger RNA (mRNA)IBA 01/2021 - 07/2007
4	Transcription Factors (Transcription Factor)IBA 08/2020 - 03/2012
4	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 04/2008
3	pembrolizumabIBA 01/2022 - 01/2021
3	Cetuximab (Erbitux)FDA Link 04/2016 - 03/2013
3	Capecitabine (Xeloda)FDA Link 11/2011 - 07/2007
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 12/2019
2	Estrogen ReceptorsIBA 01/2021 - 04/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 04/2011
2	Phenobarbital (Luminal)FDA Link 01/2021 - 09/2015
2	human ERBB2 proteinIBA 01/2021 - 01/2016
2	Nuclear Proteins (Protein, Nuclear)IBA 12/2020 - 04/2015
2	Immune Checkpoint InhibitorsIBA 01/2020 - 06/2019
2	PlasticsIBA 03/2019 - 08/2013
2	MicroRNAs (MicroRNA)IBA 11/2018 - 04/2015
2	LigandsIBA 02/2014 - 03/2013
2	ErbB Receptors (EGF Receptor)IBA 03/2013 - 12/2010
2	N 30IBA 10/2010 - 01/2010
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2009 - 07/2007
2	Thymidine PhosphorylaseIBA 09/2009 - 07/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Pharmaceutical PreparationsIBA 10/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	10-propargyl-10-deazaaminopterin FDA Link 01/2021
1	PanobinostatIBA 01/2021
1	CarcinogensIBA 01/2021
1	Orphan Nuclear ReceptorsIBA 08/2020
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2020
1	tremelimumabIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	durvalumabIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2019
1	TensinsIBA 12/2019
1	Estrogen Receptor betaIBA 12/2019
1	Keratin-5 (Keratin 5)IBA 12/2019
1	AntibodiesIBA 06/2019

Therapy/Procedure

24	Therapeutics 01/2022 - 12/2010
12	Radiotherapy 01/2022 - 07/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
4	Induction Chemotherapy 04/2022 - 01/2017
4	Neoadjuvant Therapy 04/2022 - 01/2019
3	Immunotherapy 04/2022 - 12/2020
3	Neck Dissection (Radical Neck Dissection) 04/2022 - 10/2013
2	Adjuvant Radiotherapy 03/2016 - 01/2016
2	Chemoradiotherapy 01/2016 - 11/2011
1	Combined Modality Therapy 06/2020
1	Adjuvant Chemotherapy 01/2019